Theprint
Blockbuster diabetes & obesity drug gets nod for India launch but may be available only next year
“After detailed deliberation, the committee recommended for grant of permission for import and marketing of tirzepatide 2.5mg/0.5ml, 5mg/0.5ml, 7.5mg/0.5ml, 10mg/0.5ml, 12.5mg ...
1 day ago